HOW DO YOU HELP EMPOWER SMOKERS


TO QUIT? Combination therapy is more effective in helping smokers to quit, compared with a single NRT.


1


Recommend NICORETTE dual support ®


Combination NRT vs Single NRT odds ratio 1.43 (95%Cl 1.08 to 1.91) 1. Cahill K et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews 2013, Issue 5.


1


Nicorette Invisi Patch. Presentation: Transdermal patches releasing a nominal of 25mg, 15mg or 10mg of nicotine per 16 hours. Uses: Nicorette Invisi patch relieves and/or prevents cravings and nicotine withdrawal symptoms associated with tobacco dependence. It is indicated to aid smokers wishing to quit or reduce prior to quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. Nicorette Invisi patch is indicated in pregnant and lactating women making a quit attempt. Legal category: GSL. PL holder: McNeil Products Limited, Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UG, UK. Information about this product, including adverse reactions,


precautions, contraindications, and method of use can be found at: http://www.mhra.gov.uk/


spc-pil/?IdcService=SS_GET_PAGE&nodeId=%3C%25%3D+nodeId+%25%3E&searchFiled=nicorette+invisi& Su bmitSearch=Search#retainDisplay


Nicorette QuickMist 1mg/spray mouthspray. Presentation: Each 0.07ml contains 1mg nicotine corresponding to 1 mg nicotine/spray dose. Uses: Nicorette QuickMist relieves and/or prevents cravings and nicotine withdrawal symptoms associated with tobacco dependence. It is indicated to aid smokers wishing to quit or reduce prior to


quitting, to assist smokers who are unwilling or unable to smoke, and as a safer alternative to smoking for smokers and those around them. Nicorette QuickMist is indicated in pregnant and lactating women making a quit attempt. Legal category: GSL. PL holder: McNeil Products Limited, Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UG, UK. Information about this product, including adverse reactions, precautions, contraindications, and method of use can be found at: https://www.medicines.org.uk/emc/medicine/24257


Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to McNeil Products Limited on 01344 864 042.


Date of Preparation: May 2017 UK/NI/17-9187


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32